MarketsandMarkets Blog

The global Age-related Macular Degeneration (AMD) Drugs Market is projected to grow from USD 10.46 billion in 2024 to USD 17.37 billion by 2029, registering a CAGR of 10.7% during the forecast period. The market is witnessing robust growth fueled by rising prevalence of AMD, increasing geriatric population, and rapid advancements in retinal drug development. Download...